These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 9217825)

  • 21. [Multiple sebaceous tumors with colon cancer--Muir-Torre syndrome].
    Vajda A; Scharrer K; Baló-Banga JM
    Orv Hetil; 2003 May; 144(20):985-9. PubMed ID: 12830729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cutaneous sebaceous neoplasms as markers of Muir-Torre syndrome: a diagnostic algorithm.
    Abbas O; Mahalingam M
    J Cutan Pathol; 2009 Jun; 36(6):613-9. PubMed ID: 19515040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunosuppression and sebaceous tumors: a confirmed diagnosis of Muir-Torre syndrome unmasked by immunosuppressive therapy.
    Landis MN; Davis CL; Bellus GA; Wolverton SE
    J Am Acad Dermatol; 2011 Nov; 65(5):1054-1058.e1. PubMed ID: 21550136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Torre syndrome with gastrointestinal polyposis.
    Schwartz RA; Flieger DN; Saied NK
    Arch Dermatol; 1980 Mar; 116(3):312-4. PubMed ID: 7369749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Muir-Torre syndrome: a rare variant of hereditary nonpolyposis colorectal cancer associated with hMSH2 mutation.
    Suspiro A; Fidalgo P; Cravo M; Albuquerque C; Ramalho E; Leitão CN; Costa Mira F
    Am J Gastroenterol; 1998 Sep; 93(9):1572-4. PubMed ID: 9732950
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Considerations on the performance of immunohistochemistry for mismatch repair gene proteins in cases of sebaceous neoplasms and keratoacanthomas with reference to Muir-Torre syndrome.
    Fernandez-Flores A
    Am J Dermatopathol; 2012 Jun; 34(4):416-22. PubMed ID: 22123265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Muir Torre syndrome and MSH2 mutations: the importance of dermatological awareness.
    Tischkowitz M; Gologan A; Srolovitz H; Khanna M; Foulkes WD
    Br J Cancer; 2006 Jul; 95(2):243-4. PubMed ID: 16786041
    [No Abstract]   [Full Text] [Related]  

  • 28. An illustrative case of Muir-Torre syndrome: contribution of immunohistochemical analysis in identifying indicator sebaceous lesions.
    Marazza G; Masouyé I; Taylor S; Prins C; Gaudin T; Saurat JH; French LE
    Arch Dermatol; 2006 Aug; 142(8):1039-42. PubMed ID: 16924054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Muir-Torre syndrome: a disease of sebaceous and colonic neoplasms.
    Schwartz RA; Goldberg DJ; Mahmood F; DeJager RL; Lambert WC; Najem AZ; Cohen PJ
    Dermatologica; 1989; 178(1):23-8. PubMed ID: 2917677
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A Muir-Torre syndrome family.
    Serleth HJ; Kisken WA
    Am Surg; 1998 Apr; 64(4):365-9. PubMed ID: 9544152
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A case of multiple sebaceous epithelioma: analysis of microsatellite instability.
    Ueda M; Wang Y; Sugimura H; Tamura S; Kondoh M; Ichihashi M
    J Dermatol; 1999 Mar; 26(3):178-82. PubMed ID: 10209926
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical follow-up and presence of visceral tumors in 12 patients with sebaceous gland tumors].
    Mercader P; García-Melgares ML; Roche E; Sánchez-Carazo JL; Alegre-de Miquel V
    Actas Dermosifiliogr; 2008 Sep; 99(7):532-9. PubMed ID: 18682166
    [TBL] [Abstract][Full Text] [Related]  

  • 33. All patients with sebaceous gland neoplasms should be screened for Muir-Torre syndrome.
    Ingram JR; Griffiths AP; Roberts DL
    Clin Exp Dermatol; 2009 Mar; 34(2):264-6. PubMed ID: 19187311
    [No Abstract]   [Full Text] [Related]  

  • 34. An association between sebaceous carcinoma and microsatellite instability in immunosuppressed organ transplant recipients.
    Harwood CA; Swale VJ; Bataille VA; Quinn AG; Ghali L; Patel SV; Dove-Edwin I; Cerio R; McGregor JM
    J Invest Dermatol; 2001 Feb; 116(2):246-53. PubMed ID: 11180000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Two patients with Muir-Torre syndrome].
    Vermeer MH; Neering H; Menko FH
    Ned Tijdschr Geneeskd; 1999 Sep; 143(39):1980. PubMed ID: 10610483
    [No Abstract]   [Full Text] [Related]  

  • 36. The Muir-Torre syndrome in a black patient with AIDS: histopathology and molecular genetic studies.
    Warschaw KE; Eble JN; Hood AF; Wolverton SE; Halling KC
    J Cutan Pathol; 1997 Sep; 24(8):511-8. PubMed ID: 9331898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Frequency of microsatellite instability in unselected sebaceous gland neoplasias and hyperplasias.
    Kruse R; Rütten A; Schweiger N; Jakob E; Mathiak M; Propping P; Mangold E; Bisceglia M; Ruzicka T
    J Invest Dermatol; 2003 May; 120(5):858-64. PubMed ID: 12713593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Facial sebaceous carcinoma: Muir-Torre syndrome].
    Arias-Santiago S; Soriano Hernández MI; Aneiros-Fernández J; Gutiérrez Salmerón MT; Aneiros Cachaza J; Naranjo Sintes R
    Med Clin (Barc); 2010 Jul; 135(6):291. PubMed ID: 19833357
    [No Abstract]   [Full Text] [Related]  

  • 39. A case of Muir-Torre syndrome with a keratoacanthoma and sebaceous neoplasms: Clinicopathological features and a speculation on the pathogenesis of cutaneous tumor type.
    Takayama E; Yoshioka A; Takai T; Goto K
    J Dermatol; 2021 May; 48(5):690-694. PubMed ID: 33523490
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synchronous gastric and sebaceous cancers, a rare manifestation of MLH1-related Muir-Torre syndrome.
    Svec J; Schwarzová L; Janošíková B; Stekrová J; Mandys V; Kment M; Vodička P
    Int J Clin Exp Pathol; 2014; 7(8):5196-202. PubMed ID: 25197397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.